Richards, Merrill & Peterson’s Thermo Fisher Scientific TMO Stock Holding History

Richards, Merrill & Peterson’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-91	Closed	-$45.3K	–	450
2025 Q1	$45.3K	Buy	91 +2	+2%	+$1.08K	0.02%	258
2024 Q4	$46.3K	Buy	+89	New	+$48.9K	0.02%	247

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Richards, Merrill & Peterson's TMO Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 91 shares — an estimated $45.3K sold.

Richards, Merrill & Peterson first reported a position in TMO in Q4 2024 and held it in 2 quarters. The position peaked at $46.3K in Q4 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Richards, Merrill & Peterson reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Richards, Merrill & Peterson sold 91 Thermo Fisher Scientific shares in Q2 2025, an estimated $45.3K.
Richards, Merrill & Peterson first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 2 quarters.
Richards, Merrill & Peterson's Thermo Fisher Scientific position peaked at $46.3K in Q4 2024.
2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.